The Award Ceremony of 2021 Top 20 of Deloitte Shenzhen High-Tech High-Growth Groups and Rising Star Enterprises was successfully held On October 28 in 2021. Bemei Pharma was listed on the 2021 Shenzhen Rising Star Enterprises List.

The Shenzhen Regional selection is co-sponsored by Deloitte China and Shenzhen Business Federation, aiming to discover and commend outstanding companies with high growth and continuous innovation in Shenzhen. 

Approximately 200 companies in Shenzhen participated in the selection this time. After more than 4 months of data review and on-site roadshows, Shenzhen Beimei Pharma's performance was unanimously praised by the judges and was awarded the "Deloitte Shenzhen High-tech High-growth Rising Star". Government leaders, renowned scholars, mainstream media reporters and many enterprise representatives witnessed the birth of the award.

The "Deloitte High-Tech High-Growth" selection project was founded in 1995 in Silicon Valley, USA, and entered China in 2005. It is held annually in more than 30 countries around the world and is regarded as the benchmark for global high-growth companies. Many industry leaders have emerged in the previous lists of "Deloitte High-Tech High-Growth" and "Deloitte Rising Star", such as: Microsoft, Apple, Google, Alibaba, Tencent, WuXi AppTec, Baidu, Toutiao, DJI, and etc.、

In the interview with Shenzhen News, Ms. Wu Guangmei, Chairman and CEO of Beimei Pharma, said: “Shenzhen is a vibrant and creative city, and innovation has become the label of Shenzhen. Since the establishment, Bemei has focused on the field of pediatric prescription medicine. Through the combination of generic and innovation, Bemei has taken R&D and the introduction of pediatric products from domestic and abroad as its strategic direction, continuously attract talents, innovation-driven high-quality development and enhanced the core competitiveness of the enterprise.

 Bemei aims to become a new type of pharmaceutical enterprise integrating R&D, introduction, production and sales to provide Chinese pediatric patients with convenient, precise, excellent-tasting and high-quality products.”